Suggestions
Share
Journal Information
Vol. 38. Issue 3.
Pages 231 (March 2019)
Artigo Recomendado do Mês
Open Access
Breve Comentário Vídeo ao Artigo Recomendado do Mês
Brief Comment Video to the Recommended Article of the Month
Visits
3707
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Statistics
Figures (1)
Full Text

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta‐analysis of cardiovascular outcome trials

Thomas A. Zelniker, Stephan D. Wiviott, Itamar Raz, Kyungah Im, Erica L. Goodrich, Marc P. Bonaca, Ofri Mosenzon, Eri T. Kato, Avivit Cahn, Remo H. M. Furtado, Deepak L. Bahatt, Lawrence A. Leiter, Darren K. McGuire, John P. H. Wilding, Marc S. Sabatine (in Lancet 2019;393:31‐39)

Entrevistada: Cristina Gavina

Entrevistador: Ricardo Fontes‐Carvalho

Link: https://www.youtube.com/watch?v=IeUqwbhKVm0&list=PL‐uOq5lzrAwa8yYWWoJ9RQphZyY3DVyEx∈dex=12

Conflito de interesses

Os autores declaram não haver conflito de interesses.

Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools